OTC Markets OTCPK - Delayed Quote USD

(SOFWF)

4.3500

0.0000

(0.00%)

At close: April 23 at 4:00:00 PM EDT

Sofwave’s liftHD Body Contouring Applicator to Debut at the 44th Annual Meeting of the American Society for Laser Medicine and Surgery (ASLMS) 2025

Launch of the liftHD body applicator provides opportunity for next generation non-invasive aesthetic body treatments which improve cellulite and skin laxity appearance in order to achieve SUPERB results beyond the face Four abstract poster presentations highlighting clinical applications and results of Sofwave’s SUPERB™ non-invasive medical aesthetic technology will also be on exhibit SAN CLEMENTE, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (“the Company”) (TASE: SOFW), an em

GlobeNewswire 3 days ago

SOFWF
0.00%
Sofwave’s SUPERB™ Non-Invasive Skin Treatment Technology Receives Regulatory Clearance in Japan Significantly Expanding its Coverage of the APAC Region

Japan represents third largest non-surgical medical aesthetic market in the worldSAN CLEMENTE, Calif., April 21, 2025 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (“the Company”) (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices, today announced that Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) has granted the Company approval to commercially market Sofwave’s SUPERB™ Technology. Market approval in Japan further extends Sofwave’s sales reach in the A

GlobeNewswire 6 days ago

SOFWF
0.00%
Sofwave to Participate in Upcoming Conferences

SAN CLEMENTE, Calif., March 26, 2025 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (“the Company”) (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices, today announced that Louis Scafuri, Chief Executive Officer, and Assaf Korner, Chief Financial Officer, will participate in the following conferences: 24th Annual Needham Virtual Healthcare ConferencePresentation Format: Corporate overviewPresentation Date: Wednesday, April 9, 2025Presentation Time: 9:30 a.m. ETWebc

GlobeNewswire last month

SOFWF
0.00%
Sofwave Medical Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights

– Fourth quarter revenue of $18.3M, +20% year-over-year growth; IFRS gross margin of 77.0% – Full fiscal 2024 revenue of $59.7M, +19% year-over-year growth; IFRS gross margin of 76.0% – Full fiscal 2024 pulse recurring revenue of $23.3M, +79% year-over-year growth – Nearing breakeven, as IFRS operating loss narrowed to -$0.1M in the fourth quarter; generated non-IFRS fourth quarter operating profit of $0.6M SAN CLEMENTE, Calif., March 05, 2025 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (TASE: SOFW)

GlobeNewswire last month

SOFWF
0.00%
Sofwave Medical Reports Preliminary Unaudited Fourth Quarter and Full Fiscal Year 2024 Topline Financial Results

SAN CLEMENTE, Calif., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners worldwide, reports preliminary financial results for the fourth quarter and full fiscal year, for the period ended December 31, 2024. Preliminary financial results Fourth quarter 2024 revenue is expected to total between $18.2 million and $18.4 million, as compared to approximately $15.3 million in the same period l

GlobeNewswire 3 months ago

SOFWF
0.00%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

(SOFWF)

Sofwave’s liftHD Body Contouring Applicator to Debut at the 44th Annual Meeting of the American Society for Laser Medicine and Surgery (ASLMS) 2025

Sofwave’s SUPERB™ Non-Invasive Skin Treatment Technology Receives Regulatory Clearance in Japan Significantly Expanding its Coverage of the APAC Region

Sofwave to Participate in Upcoming Conferences

Sofwave Medical Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights

Sofwave Medical Reports Preliminary Unaudited Fourth Quarter and Full Fiscal Year 2024 Topline Financial Results